IL-35 is elevated in clinical and experimental sepsis and mediates inflammation

被引:45
|
作者
Cao, Ju [1 ]
Xu, Fang [2 ,3 ]
Lin, Shihui [2 ,3 ]
Tao, Xintong [4 ]
Xiang, Yu [1 ]
Lai, Xiaofei [1 ]
Zhang, Liping [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Emergency, Chongqing 400016, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Intens Care Unit, Chongqing 400016, Peoples R China
[4] Chongqing Med Univ, Key Lab Diagnost Med Designated, Minist Educ, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
IL-35; Sepsis; Infection; Inflammation; Immunopathogenesis; REGULATORY T-CELLS; INDUCED IMPAIRMENT; SUPPRESSION; CYTOKINE; TREG; ACTIVATION; MECHANISMS; INDUCTION; EXPRESS; MICE;
D O I
10.1016/j.clim.2015.08.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis carries considerable morbidity and mortality. IL-35 is a newly described cytokine, which plays a regulatory role in infection and immunity. In this study, we found that IL-35 concentration in serum samples from adult or child patients with sepsis was significantly higher compared with that from healthy controls. IL-35 gradually increased according to sepsis severity. Increased serum IL-35 was associated with LOD (Logistic Organ Dysfunction) or SAPS II (Simplified Acute Physiology Score) scores, and correlated with markers of inflammation. In murine abdominal sepsis, administration of anti-IL-35 p35 antibodies significantly diminished dissemination of the bacteria in septic animals, which was accompanied by enhanced local neutrophil recruitment and early increased release of inflammatory cytokines and chemokines. Therefore, sepsis is associated with enhanced release of IL-35. In abdominal sepsis, IL-35 likely facilitates bacterial dissemination. IL-35 plays a major role in the immunopathogenesis of sepsis. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 50 条
  • [1] IL-18 and IL-35 in the serum of patients with sepsis thrombocytopenia and the clinical significance
    Zhu, Meirong
    Rong, Xiaoqian
    Li, Min
    Wang, Shaoqin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (02) : 1251 - 1258
  • [2] Elevated Plasma IL-35 Predicted Poor Outcome of Sepsis-Related ARDS Patients
    Zhao, Yan
    He, Jing
    Deng, Xinyu
    Deng, Wang
    Li, Changyi
    Wang, Daoxin
    CHEST, 2016, 149 (04) : 152A - 152A
  • [3] Elevated IL-35 in bone marrow of the patients with acute myeloid leukemia
    Wang, Jia
    Tao, Qianshan
    Wang, Huiping
    Wang, Zhitao
    Wu, Fan
    Pan, Ying
    Tao, Lili
    Xiong, Shudao
    Wang, Yiping
    Zhai, Zhimin
    HUMAN IMMUNOLOGY, 2015, 76 (09) : 681 - 686
  • [4] The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis
    Liguo Yin
    Yongpeng Ge
    Hanbo Yang
    Qinglin Peng
    Xin Lu
    Yamei Zhang
    Guochun Wang
    Clinical Rheumatology, 2016, 35 : 2715 - 2721
  • [5] The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis
    Yin, Liguo
    Ge, Yongpeng
    Yang, Hanbo
    Peng, Qinglin
    Lu, Xin
    Zhang, Yamei
    Wang, Guochun
    CLINICAL RHEUMATOLOGY, 2016, 35 (11) : 2715 - 2721
  • [6] Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity
    Li, Yuxuan
    Yao, Lutian
    Liu, Siyan
    Wu, Jisheng
    Xia, Liping
    Shen, Hui
    Lu, Jing
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (03) : 707 - 710
  • [7] CD25+B cells produced IL-35 and alleviated local inflammation during experimental periodontitis
    Han, Yakun
    Yu, Chengcheng
    Yu, Yan
    Bi, Liangjia
    ORAL DISEASES, 2022, 28 (08) : 2248 - 2257
  • [8] IL-35 interferes with splenic T cells in a clinical and experimental model of acute respiratory distress syndrome
    Wang, Chuan-jiang
    Zhang, Mu
    Wu, Hua
    Lin, Shi-hui
    Xu, Fang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 386 - 395
  • [9] SERUM IL-35 LEVELS IN SYSTEMIC SCLEROSIS AND RELATIONSHIP WITH CLINICAL FEATURES
    Yayla, M. E.
    Torgutalp, M.
    Okatan, I. E.
    Yurteri, E. Uslu
    Kucuksahin, O.
    Dincer, A. B. Kelesoglu
    Guloksuz, E. G. Aydemir
    Sezer, S.
    Us, E.
    Turgay, T. M.
    Kinikli, G.
    Ales, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1506 - 1506
  • [10] IL-35 and Autoimmunity: a Comprehensive Perspective
    Jinjung Choi
    Patrick S. C. Leung
    Christopher Bowlus
    M. Eric Gershwin
    Clinical Reviews in Allergy & Immunology, 2015, 49 : 327 - 332